Screening for vancomycin-resistant enterococci using stools sent for clostridium difficile cytotoxin assay is effective: Results of a survey of 300 patients in a large Singapore teaching hospital

Annals of the Academy of Medicine Singapore

Volumn 36, Issue 11, 2007, Pages 926-929

  Tay, Joshua K X ^a   Bodle, Ethan E ^b   Fisher, Dale A ^a,c   Lin, Raymond V T P ^c   Kumarasinghe, Gamini ^c   Tambyah, Paul A ^a,c  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b Columbia University College of Physicians and Surgeons ^*  (United States)

^c NATIONAL UNIVERSITY HOSPITAL   (Singapore)

Author keywords

Antibiotic resistance; Surveillance; Vancomycin resistant enterococci

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIBIOTIC AGENT; CEPHALOSPORIN DERIVATIVE; CLOSTRIDIUM DIFFICILE TOXIN A; CLOSTRIDIUM DIFFICILE TOXIN B; METRONIDAZOLE; QUINOLONE DERIVATIVE; VANCOMYCIN;

ADULT; AGED; BACTERIAL COLONIZATION; BACTERIUM DETECTION; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; CLOSTRIDIUM DIFFICILE; CONFERENCE PAPER; CONTROLLED STUDY; CULTURE MEDIUM; DIABETES MELLITUS; DNA FINGERPRINTING; DRUG EXPOSURE; ENTEROCOCCAL INFECTION; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; FECES ANALYSIS; FECES CULTURE; FEMALE; HEALTH SURVEY; HIGH RISK PATIENT; HOSPITAL INFECTION; HUMAN; INFECTION RISK; KIDNEY FAILURE; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; NEOPLASM; POLYMERASE CHAIN REACTION; PREVALENCE; SCREENING TEST; SINGAPORE; TEACHING HOSPITAL; VANCOMYCIN RESISTANT ENTEROCOCCUS; VARIABLE NUMBER OF TANDEM REPEAT;

EID: 38049100659     PISSN: 03044602     EISSN: 29724066     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (20)

1. Hospital Infection Control Practices Advisory Committee (HICPAC). Recommendations for preventing the spread of vancomycin resistance. Infect Control Hosp Epidemiol 1995;16:105-13. Erratum in: Infect Control Hosp Epidemiol 1995;16:498.
2. Christiansen KJ, Tibbett PA, Beresford W, Pearman JW, Lee RC, Coombs GW, et al. Eradication of a large outbreak of a single strain of vanB vancomycin-resistant Enterococcus faecium at a major Australian teaching hospital. Infect Control Hosp Epidemiol 2004;25:384-90.
3. Nourse C, Byrne C, Murphy H, Kaufmann ME, Clarke A, Butler K. Eradication of vancomycin-resistant Enterococcus faecium from a paediatric oncology unit and prevalence of colonization in hospitalized and community-based children. Epidemiol Infect 2000;124:53-9.
4. Hendrix CW, Hammond JM, Swoboda SM, Merz WG, Harrington SM, Perl TM, et al. Surveillance strategies and impact of vancomycin-resistant enterococcal colonization and infection in critically ill patients. Ann Surg 2001;233:259-65.
5. Chavers LS, Moser SA, Benjamin WH, Banks SE, Steinhauer JR, Smith AM, et al. Vancomycin-resistant enterococci: 15 years and counting. J Hosp Infect 2003;53:159-71.
6. Beltrami EM, Singer DA, Fish L, Manning K, Young S, Banerjee SN, et al. Risk factors for acquisition of vancomycin-resistant enterococci among patients on a renal ward during a community hospital outbreak. Am J Infect Control 2000;28:282-5.
7. Safdar N, Maki DG. The commonality of risk factors for nosocomial colonization and infection with antimicrobial-resistant Staphylococcus aureus, enterococcus, gram-negative bacilli, Clostridium difficile, and Candida. Ann Intern Med 2002;136:834-44.
8. Rafferty ME, McCormick MI, Bopp LH, Baltch AL, George M, Smith RP, et al. Vancomycin-resistant enterococci in stool specimens submitted for Clostridium difficile cytotoxin assay. Infect Control Hosp Epidemiol 1997;18:342-4.
9. Ang SW, Seah CS, Lee ST. Vancomycin-resistant Enterococcus in the Singapore National Burns Centre: a case report. Ann Acad Med Singapore 1996;25:270-2.
10. Chlebicki MP, Ling ML, Koh TH, Hsu LY, Tan BH, How KB, et al. First outbreak of vancomycin-resistant Enteroccous faecium in a tertiary-care hospital in Singapore. Epidemiological News Bulletin, Ministry of Health, Singapore 2005;31:23-6.
11. Dutka-Malen S, Evers S, Courvalin P. Detection of glycopeptide resistance genotypes and identification to the species level of clinically relevant enterococci by PCR. J Clin Microbiol 1995;33:24-27. Erratum in: J Clin Microbiol 1995;33:1434.
12. Top J, Schouls LM, Bonten MJ, Willems RJ. Multiple-locus variable-number tandem repeat analysis, a novel typing scheme to study the genetic relatedness and epidemiology of Enterococcus faecium isolates. J Clin Microbiol 2004;42:4503-11.
13. Leclercq R, Derlot E, Duval J, Courvalin P. Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium. N Engl J Med 1988;319:157-61.
14. NNIS System. National Nosocomial Infections Surveillance (NNIS) system report, data summary from January 1992 to June 2003, issued August 2003. Am J Infect Control 2003;31:481-98.
15. NNIS System. National Nosocomial Infections Surveillance (NNIS) system report, data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control 2004;32:470-85.
16. Leclercq R, Derlot E, Weber M, Duval J, Courvalin P. Transferable vancomycin and teicoplanin resistance in Enterococcus faecium. Antimicrob Agents Chemother 1989;33:10-5.
17. Gerding DN. Is there a relationship between vancomycin-resistant enterococcal infection and Clostridium difficile infection? Clin Infect Dis 1997;25:S206-S210.
18. Ray AJ, Hoven CK, Das SM, Eckstein EC, Donskey CJ. Undetected vancomycin-resistant Enterococcus stool colonization in a Veterans Affairs Hospital using a Clostridium difficile-focused surveillance strategy. Infect Control Hosp Epidemiol 2002;23:474-7.
19. Katz KC, Gardam MA, Burt, J, Conly JM. A comparison of multifaceted versus Clostridium difficile-focused VRE surveillance strategies in a low-prevalence setting. Infect Control Hosp Epidemiol 2001;22:219-21.
20. Fisher DA, Lin R, Chai L, Kumarasinghe G, Singh K, Tambyah PA. Vancomycin-resistant enterococci in a Singapore teaching hospital prior to 2005. Singapore Med J 2005;46:311-2.